am meisten angesehen - Myopic Macular Degeneration - Wet
Myopic CNVM in the left eye. New Classic subfoveal lesion414 x angesehen64 year old female. She had retinal detachment repair in the right eye in 1996 (25 years ago). The left eye has new distortion for a week or two.
VA 20/40 OU.
Left eye has a very small subfoveal CNVM
Myopic CNVM in the left eye. New Classic subfoveal lesion412 x angesehen64 year old female. She had retinal detachment repair in the right eye in 1996 (25 years ago). The left eye has new distortion for a week or two.
VA 20/40 OU.
Left eye has a very small subfoveal CNVM
Rapid macular atrophy with anti-VEGF therapy for myopic CNVM410 x angesehen64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
Rapid macular atrophy with anti-VEGF therapy for myopic CNVM410 x angesehen64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
Rapid macular atrophy with anti-VEGF therapy for myopic CNVM409 x angesehen64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
Rapid macular atrophy with anti-VEGF therapy for myopic CNVM408 x angesehen64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
Rapid macular atrophy with anti-VEGF therapy for myopic CNVM407 x angesehen64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
Rapid macular atrophy with anti-VEGF therapy for myopic CNVM406 x angesehen64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
Rapid macular atrophy with anti-VEGF therapy for myopic CNVM406 x angesehen64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
Rapid macular atrophy with anti-VEGF therapy for myopic CNVM405 x angesehen64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
Rapid macular atrophy with anti-VEGF therapy for myopic CNVM404 x angesehen64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
Rapid macular atrophy with anti-VEGF therapy for myopic CNVM404 x angesehen64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
Rapid macular atrophy with anti-VEGF therapy for myopic CNVM403 x angesehen64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
Rapid macular atrophy with anti-VEGF therapy for myopic CNVM402 x angesehen64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
Rapid macular atrophy with anti-VEGF therapy for myopic CNVM401 x angesehen64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
Rapid macular atrophy with anti-VEGF therapy for myopic CNVM401 x angesehen64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
Rapid macular atrophy with anti-VEGF therapy for myopic CNVM399 x angesehen64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
Myopic CNVM in the left eye. New Classic subfoveal lesion399 x angesehen64 year old female. She had retinal detachment repair in the right eye in 1996 (25 years ago). The left eye has new distortion for a week or two.
VA 20/40 OU.
Left eye has a very small subfoveal CNVM
Rapid macular atrophy with anti-VEGF therapy for myopic CNVM398 x angesehen64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
Rapid macular atrophy with anti-VEGF therapy for myopic CNVM396 x angesehen64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
Myopic CNVM in the left eye. New Classic subfoveal lesion394 x angesehen64 year old female. She had retinal detachment repair in the right eye in 1996 (25 years ago). The left eye has new distortion for a week or two.
VA 20/40 OU.
Left eye has a very small subfoveal CNVM
Rapid macular atrophy with anti-VEGF therapy for myopic CNVM393 x angesehen64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
Myopic CNVM in the left eye. New Classic subfoveal lesion393 x angesehen64 year old female. She had retinal detachment repair in the right eye in 1996 (25 years ago). The left eye has new distortion for a week or two.
VA 20/40 OU.
Left eye has a very small subfoveal CNVM
Rapid macular atrophy with anti-VEGF therapy for myopic CNVM387 x angesehen64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
Myopic CNVM in the left eye. New Classic subfoveal lesion387 x angesehen64 year old female. She had retinal detachment repair in the right eye in 1996 (25 years ago). The left eye has new distortion for a week or two.
VA 20/40 OU.
Left eye has a very small subfoveal CNVM
Rapid macular atrophy with anti-VEGF therapy for myopic CNVM377 x angesehen64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
Rapid macular atrophy with anti-VEGF therapy for myopic CNVM375 x angesehen64 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years269 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years266 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years264 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years263 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years263 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years259 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years255 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years248 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years244 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years240 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years240 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years240 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years238 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years236 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years236 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years236 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years235 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years234 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years234 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years228 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years227 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years226 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years225 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years225 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years224 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years220 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years220 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years220 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years219 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years215 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years214 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years213 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic CNVM Left Eye211 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic CNVM Left Eye211 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years210 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years209 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic CNVM Left Eye209 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years206 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years206 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years206 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic CNVM Left Eye206 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years204 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years203 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic CNVM Left Eye197 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years196 x angesehen31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic CNVM Left Eye196 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic CNVM Left Eye193 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic CNVM Left Eye185 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic CNVM Left Eye185 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic CNVM Left Eye183 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic CNVM Left Eye181 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic CNVM Left Eye181 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic CNVM Left Eye180 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic CNVM Left Eye179 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic CNVM Left Eye177 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic CNVM Left Eye177 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic CNVM Left Eye176 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic CNVM Left Eye175 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic CNVM Left Eye173 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic CNVM Left Eye172 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic CNVM Left Eye171 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic CNVM Left Eye167 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic CNVM Left Eye167 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic CNVM Left Eye167 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic CNVM Left Eye166 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic CNVM Left Eye166 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic CNVM Left Eye166 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic CNVM Left Eye162 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic CNVM Left Eye160 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic CNVM Left Eye157 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic CNVM Left Eye154 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic CNVM Left Eye149 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
Myopic CNVM Left Eye148 x angesehen80 year old female. VA dropped to 20/125 but improved back up to 20/50 with Vabysmo
